Fortrea Holdings (FTRE)

Profile

Full Name

Fortrea Holdings Inc.

Ticker Symbol

FTRE

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

June 20, 2023

Indexes

Not included

Website

http://www.fortrea.com

Employees

15500

Key Details

Price

$4.93(-1.79%)

Market cap

$444.69M(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$2.70B(-5.14% YoY)

Annual EPS

-$3.67(-1165.52% YoY)

PE ratio

-

Next earnings date

May 12, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$4.93
FTRE price is $4.93

30-Day Relative Volume

1.12
FTRE 30-day relative volume is 1.12

Price Performance

Price Today change

-1.79%
FTRE price is down -1.79% today

Price YTD change

-73.57%
FTRE price is down -73.57% since January 1st

Price 1-year change

-86.5%
FTRE price is down -86.5% year-on-year

Price 3-year change

-
FTRE price 3-year change is unknown

Price Range

Price All-time high

$41.02
FTRE price is currently -87.98% below its historical high of $41.02

Price 3-year low

$4.77
FTRE price is currently +3.35% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$444.69M
FTRE market capitalization is $444.69 million

Market cap 3-year change

-
FTRE market capitalization 3-year change is unknown

Market cap All-time high

$3.60B
FTRE market capitalization is currently -87.65% below its historical high of $3.60 billion

Market cap sector rank

67.85%
FTRE market capitalization is higher than 67.85% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+0.92%
FTRE shares outstanding is up +0.92% year-on-year

Shares Outstanding 3-Year Change

-
FTRE shares outstanding 3-year change is unknown

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

1.62
FTRE beta is 1.62

200-day SMA

$18.35
FTRE price is currently -73.13% below its 200-day simple moving average

50-day SMA

$10.53
FTRE price is currently -53.18% below its 50-day simple moving average

RSI

25.45
FTRE 14-day relative strength index is 25.45

Volume

1.12
FTRE 30-day relative volume is 1.12

ATR

$0.64
FTRE average true range is $0.64

10-day Historical Volatility

143.20%
FTRE 10-day historical volatility is 143.20%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$2.70B
FTRE annual revenue is $2.70 billion

Revenue Analysts estimate

$2.49B
FTRE annual revenue is currently +8.31% higher than the consensus analysts' forecast

Revenue 1-year change

-5.14%
FTRE annual revenue is down -5.14% year-on-year

Revenue Sector rank

87.12%
FTRE annual revenue is higher than 87.12% of companies in Healthcare sector

EPS

EPS

-$3.67
FTRE annual earnings per share is -$3.67

EPS Analysts estimate

$0.43
FTRE annual earnings per share is currently -945.04% lower than the consensus analysts' forecast

EPS 1-year change

-1165.52%
FTRE annual earnings per share is down -1165.52% year-on-year

EPS Sector rank

24.79%
FTRE annual earnings per share is higher than 24.79% of companies in Healthcare sector

Profit

Gross profit

$534.20M
FTRE annual gross profit is $534.20 million

Gross margin

19.81%
FTRE annual gross profit margin is 19.81%

Operating profit

-$111.80M
FTRE annual operating income is -$111.80 million

Operating margin

-4.15%
FTRE annual operating profit margin is -4.15%

Net income

-$328.50M
FTRE annual net profit is -$328.50 million

Net margin

-12.18%
FTRE annual net profit margin is -12.18%

Expenses

Total expenses

$2.81B
FTRE annual total expenses is $2.81 billion

Operating expenses

$646.00M
FTRE annual total operating expenses is $646.00 million

Cost of goods sold

$2.16B
FTRE annual cost of goods sold is $2.16 billion

Selling, general & administrative expenses

$560.70M
FTRE annual SGA is $560.70 million

Depreciation and amortization

$86.90M
FTRE annual depreciation & amortization is $86.90 million

Interest expense

$123.80M
FTRE annual interest expense is $123.80 million

Income tax

-$3.50M
FTRE annual income tax is -$3.50 million

EBIT & EBITDA

EBIT

-$151.20M
FTRE annual earnings before interest & taxes is -$151.20 million

EBITDA

-$64.30M
FTRE annual EBITDA is -$64.30 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$3.58B
FTRE annual total assets is $3.58 billion

Non current assets

$2.63B
FTRE annual long term assets is $2.63 billion

Current assets

$948.20M
FTRE annual total current assets is $948.20 million

Cash and cash equivalents

$118.50M
FTRE annual cash & cash equivalents is $118.50 million

Accounts receivable

$156.50M
FTRE annual accounts receivable is $156.50 million

Inventory

-
FTRE annual inventory value is unknown

Liabilities

Total liabilities

$2.22B
FTRE annual total liabilities is $2.22 billion

Long term liabilities

$1.27B
FTRE annual total long term liabilities is $1.27 billion

Current liabilities

$949.50M
FTRE annual total current liabilities is $949.50 million

Accounts payable

$138.20M
FTRE annual accounts payable is $138.20 million

Debt

Total debt

$1.20B
FTRE annual total debt is $1.20 billion

Total debt 1-year change

-28.32%
FTRE annual total debt is down -28.32% year-on-year

Long term debt

$1.11B
FTRE annual long term debt is $1.11 billion

Short term debt

$88.20M
FTRE annual short term debt is $88.20 million

Equity & Capital

Shareholders equity

$1.36B
FTRE annual stockholders equity is $1.36 billion

Book value

$1.36B
FTRE annual book value is $1.36 billion

Retained earnings

-$397.00M
FTRE annual retained earnings is -$397.00 million

Working capital

-$1.30M
FTRE annual working capital is -$1.30 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

$262.80M
FTRE annual cash flow from operations is $262.80 million

Cash from operations 1-year change

+56.06%
FTRE annual cash flow from operations is up +56.06% year-on-year

Cash from investing

$251.60M
FTRE annual cash flow from investing activities is $251.60 million

Cash from investing 1-year change

+891.19%
FTRE annual cash flow from investing activities is up +891.19% year-on-year

Cash from financing

-$497.80M
FTRE annual cash flow from financing activities is -$497.80 million

Cash from financing 1-year change

-253.55%
FTRE annual cash flow from financing activities is down -253.55% year-on-year

CAPEX

CAPEX

$25.50M
FTRE annual capital expenditures is $25.50 million

CAPEX 1-year change

-36.72%
FTRE annual capital expenditures is down -36.72% year-on-year

Free Cash Flow

Free cash flow

$237.30M
FTRE annual free cash flow is $237.30 million

Free cash flow 1-year change

+85.25%
FTRE annual free cash flow is up +85.25% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

19.81%
FTRE annual gross profit margin is 19.81%

Operating margin

-4.15%
FTRE annual operating profit margin is -4.15%

Net margin

-12.18%
FTRE annual net profit margin is -12.18%

ROA & ROE

ROA

-8.30%
FTRE annual return on assets is -8.30%

ROE

-21.36%
FTRE annual return on equity is -21.36%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
FTRE price to earnings ratio value is unknown

PE ratio Sector rank

-
FTRE price to earnings ratio is unknown

PB Ratio

PB ratio

0.33
FTRE price to book ratio is 0.33

PB ratio Sector rank

24.63%
FTRE price to book ratio is higher than 24.63% of companies in Healthcare sector

PS Ratio

PS ratio

0.16
FTRE price to sales ratio is 0.16

PS ratio Sector rank

6.54%
FTRE price to sales ratio is higher than 6.54% of companies in Healthcare sector

Enterprise value

Enterprise value

$1.52B
FTRE enterprise value is $1.52 billion

Enterprise value Sector rank

79.44%
FTRE enterprise value is higher than 79.44% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-23.71
FTRE EV/EBITDA is -23.71

EV/EBITDA Sector rank

5.39%
FTRE EV/EBITDA is higher than 5.39% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

1.00
FTRE annual current ratio is 1.00

Quick ratio

-
FTRE annual quick ratio value is unknown

Leverage

Debt to equity

0.83
FTRE annual debt to equity ratio is 0.83

Interest coverage ratio

-1.22
FTRE annual interest coverage ratio is -1.22

Risk & Stability

Piotroski F-Score

5
FTRE piotroski f-score is 5

Altman Z-Score

0.58
FTRE altman z-score is 0.58

Analyst ratings

Recent major analysts updates

Apr 10, 25 Barclays
Underweight
Apr 9, 25 Mizuho
Neutral
Mar 4, 25 William Blair
Market Perform
Mar 4, 25 Goldman Sachs
Neutral
Mar 4, 25 Evercore ISI Group
In-Line
Mar 4, 25 Barclays
Equal-Weight
Dec 11, 24 Citigroup
Neutral
Dec 6, 24 Baird
Neutral
Nov 25, 24 Baird
Outperform
Nov 11, 24 TD Cowen
Hold

Institutional Ownership

Similar stocks

SAGE logo
Sage Therapeutics (SAGE)
Upstream Bio (UPB)
MDRX logo
Veradigm (MDRX)
TYRA logo
Tyra Biosciences (TYRA)
TALK logo
Talkspace (TALK)
CGEM logo
Cullinan Oncology (CGEM)
RLAY logo
Relay Therapeutics (RLAY)
KURA logo
Kura Oncology (KURA)
Sionna Therapeutics (SION)
  • What is the ticker symbol for Fortrea Holdings?
  • Does Fortrea Holdings pay dividends?
  • What sector is Fortrea Holdings in?
  • What industry is Fortrea Holdings in?
  • What country is Fortrea Holdings based in?
  • When did Fortrea Holdings go public?
  • Is Fortrea Holdings in the S&P 500?
  • Is Fortrea Holdings in the NASDAQ 100?
  • Is Fortrea Holdings in the Dow Jones?
  • When was Fortrea Holdings's last earnings report?
  • When does Fortrea Holdings report earnings?
  • Should I buy Fortrea Holdings stock now?

What is the ticker symbol for Fortrea Holdings?

The ticker symbol for Fortrea Holdings is NASDAQ:FTRE

Does Fortrea Holdings pay dividends?

No, Fortrea Holdings does not pay dividends

What sector is Fortrea Holdings in?

Fortrea Holdings is in the Healthcare sector

What industry is Fortrea Holdings in?

Fortrea Holdings is in the Biotechnology industry

What country is Fortrea Holdings based in?

Fortrea Holdings is headquartered in United States

When did Fortrea Holdings go public?

Fortrea Holdings's initial public offering (IPO) was on June 20, 2023

Is Fortrea Holdings in the S&P 500?

No, Fortrea Holdings is not included in the S&P 500 index

Is Fortrea Holdings in the NASDAQ 100?

No, Fortrea Holdings is not included in the NASDAQ 100 index

Is Fortrea Holdings in the Dow Jones?

No, Fortrea Holdings is not included in the Dow Jones index

When was Fortrea Holdings's last earnings report?

Fortrea Holdings's most recent earnings report was on Mar 3, 2025

When does Fortrea Holdings report earnings?

The next expected earnings date for Fortrea Holdings is May 12, 2025

Should I buy Fortrea Holdings stock now?

As of today, analysts generally recommend a 'Hold' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page